Logo Logo
Hilfe
Hilfe
Switch Language to English

Pusterla, Nicola; Hussey, Gisela Soboll und Goehring, Lutz S. (2022): Equine Herpesvirus-1 Myeloencephalopathy. In: Veterinary Clinics of North America-Equine Practice, Bd. 38, Nr. 2: S. 339-362

Volltext auf 'Open Access LMU' nicht verfügbar.

Abstract

Although EHM is a relatively uncommon manifestation of EHV-1 infection, it can cause devastating losses during outbreaks. Antemortem diagnosis of EHM relies mainly on the molecular detection of EHV-1 in nasal secretions and blood. Manage-ment of horses affected by EHM is aimed at supportive nursing and nutritional care, at reducing CNS inflammation, and preventing thromboembolic sequelae. Horses exhibiting sudden and severe neurologic signs consistent with a diagnosis of EHM pose a definite risk to the surrounding horse population. Consequently, early inter-vention to prevent the spread of infection is required. Disease control measures, such as isolation of affected horses, segregation and monitoring of exposed horses, and quarantine measures, should be established in order to prevent the spread of the virus. Although there are several vaccines available against both the respiratory and the abortigenic form of EHV-1 infection, currently no vaccine has a claim for the prevention of EHM.

Dokument bearbeiten Dokument bearbeiten